Authors



Richard Schwartz, BS

Latest:

Post-SNF Outcomes and Cost Comparison: Medicare Advantage vs Traditional Medicare

Patients enrolled in Medicare Advantage had better outcomes and lower cost following skilled nursing facility (SNF) discharge than patients enrolled in traditional fee-for-service Medicare.


Kimberly J. Erlich, MSN, MPH, RN, CPNP, PMHS

Latest:

Primary Care Nurse Practitioner Management of Adolescent Behavioral Health

Personnel costs ($90,514) of a primary care–embedded adolescent behavioral health nurse practitioner over 2 years were 63% of the potential revenue generated ($144,449).


Kenneth C. Hohmeier, PharmD

Latest:

Amazon Pharmacy: Distraction or Disruption?

After years of anticipation, Amazon Pharmacy launched in November 2020. The question is now: Is this market entry a disruption, a distraction, or something in between?


Cathy Eng, MD, FACP, FASCO | Image Credit: © Vanderbilt-Ingram Cancer Center
Cathy Eng, MD, FACP, FASCO

Latest:

Building Communities Around Patients: Cathy Eng, MD

Cathy Eng, MD, FACP, FASCO, participated on the panel discussion, “Health Equity in Cancer Care Delivery,” during the January Institute for Value-Based Medicine® event, “Elevating Value in Cancer Care: Nashville.”


David M. Miller, MBA

Latest:

A Standardized Care Pathway Increases Optimal Dialysis Starts

The authors observed a significant increase in optimal starts for dialysis and in peritoneal dialysis rates after implementing a standardized end-stage renal disease transition pathway.


Jordan Rosedahl, BS

Latest:

Impact of Advance Care Planning Consults on Advance Directives Completion

Implementing advance care planning consults can increase advance directive completion rates. The authors demonstrate the impact of consults on completed advance directives in the medical record.


Aisha T. Langford, PhD, MPH

Latest:

When Does Nonadherence Indicate a Deviation From Patient-Centered Care?

The authors suggest that assessment of patient-centered care may be improved by flagging probable discordance between a patient’s preferences and their treatment care plan.


Roy G. Marcus, MD

Latest:

A Standardized Care Pathway Increases Optimal Dialysis Starts

The authors observed a significant increase in optimal starts for dialysis and in peritoneal dialysis rates after implementing a standardized end-stage renal disease transition pathway.



Caleb J. Scheckel, DO

Latest:

Neulasta Onpro: A Coup de Grâce?

With the rapid decline in average sales price of reference pegfilgrastim products due to biosimilar competition, health care institutions and payers may grapple with coverage of Neulasta Onpro.


Brianna Rhue, OD, FAAO

Latest:

Experts Recount What Aspects of SECO Will Be Vital to Their Future Practice

Attendees and experts from the Southeastern Educational Congress of Optometry (SECO) 2025 meeting highlight research and sessions they will take away.


Jason Harris

Latest:

FDA Fast Tracks BCMA-Targeted CAR T-Cell Therapy for R/R Multiple Myeloma

The FDA has granted a fast track designation to CB-011, a CRISPR-edited allogeneic CAR T-cell therapy developed by Caribou Biosciences, for the treatment of patients with relapsed/refractory multiple myeloma.


Christopher M. Whinney, MD

Latest:

The Relationship Between the Follow-up to Discharge Ratio and Length of Stay

The objective was to evaluate the correlation between the follow-up to discharge ratio and average length of stay.


Charles Maynard, PhD, MSW

Latest:

Factors Associated With Primary Care Physician Turnover in the VA

This longitudinal observational study found higher team satisfaction with workload to be significantly associated with lower primary care physician turnover.


Mitch Perry

Latest:

Contributor: For Better or Worse, Inflation Isn’t New to Health Insurers

In this column, a health insurance executive discusses 2 ways to address rising inflation, including moving past the traditional fee-for-service payment model.


Ryan Scott

Latest:

Neoadjuvant KN026 Plus Docetaxel Demonstrate Early Activity in HER2+ Breast Cancer

A combination of KN026, a novel bispecific antibody, and docetaxel elicited responses with an acceptable toxicity profile when administered as neoadjuvant treatment in patients with HER2-positive (HER2+) early or locally advanced breast cancer.


Ryan Nguyen, PharmD, BCPS

Latest:

Pharmacist-Led Review of Empagliflozin and Ertugliflozin Following Formulary Update

Management of empagliflozin and ertugliflozin may be suboptimal following an insurance carrier’s formulary updates. Pharmacists may improve the management.


Jaehyeon Yun, PhD

Latest:

Predicting Hospital Readmission in Medicaid Patients With Diabetes Using Administrative and Claims Data

A statistical model based entirely on claims data can accurately predict 30-day hospital readmission in Medicaid patients with diabetes.


Scott E. Regenbogen, MD, MPH

Latest:

Hospital Strategies in Commercial Episode-Based Reimbursement

This study reports qualitative findings from an explanatory sequential mixed-methods investigation to understand hospitals’ approaches to a novel commercial episode-based reimbursement incentive program.


Seth Killion, BS

Latest:

Effects of Individualized Nurse-Led Care Plans on Olaparib Treatment Duration

A nurse-led personalized care program conducted through a specialty pharmacy prolonged medication persistence among patients with cancer receiving olaparib.



Grazia Aleppo, MD

Latest:

The Role of Advanced Technologies in Improving Diabetes Outcomes

This article reviews underlying barriers to health care access and discusses how a value-based diabetes care model could improve patient outcomes and reduce long-term costs.




Dennis G. Maki, MD

Latest:

COVID-19 Control in the United States: The Case for Masking

In the control of COVID-19, the future perfect of the vaccine should not be the enemy of the present good, which is masking.



Marta Fiocco, PhD

Latest:

Identifying Complex Patients Using Adjusted Clinical Groups Risk Stratification Tool

In this study, the authors developed a method for use in primary care to identify a group of patients with complex care needs using Aggregated Diagnosis Groups.


Lynda Charters

Latest:

ASRS 2023: Intended vs Actual Treatment Intervals Between Intravitreal Anti-VEGF Injections: Effects of Treatment Days

In the study, researchers found that nearly one-quarter of anti-VEGF injections were received at least 1 week later than intended.


Kierstin Catlett, PhD

Latest:

Potential Spillover Effects on Traditional Medicare When Physicians Bear Medicare Advantage Risk

Medicare beneficiaries treated by physicians with high levels of Medicare Advantage risk exposure had higher care quality and efficiency outcomes compared with those treated by other physicians.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo